With age, the brain undergoes both structural and functional alterations, probably resulting
in reported cognitive declines. Relatively few investigations have sought to identify those …

Gray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are well-described
hallmarks of Alzheimer's disease, but their relationships are poorly understood. The …

Purpose Positron emission tomography (PET) imaging of brain amyloid load has been
suggested as a core biomarker for Alzheimer’s disease (AD). The aim of this study was to test the …

Introduction Subjective cognitive decline (SCD) could indicate preclinical Alzheimer's disease,
but the existing literature is confounded by heterogeneous approaches to studying SCD. …

Neuroimaging biomarkers, namely hippocampal volume loss, temporoparietal hypometabolism,
and neocortical β-amyloid (Aβ) deposition, are included in the recent research criteria …

Positron emission tomography (PET) is a non-invasive imaging technology which provides
a unique window on the physiology and function of living organisms. It uses short-lived …

Objective. The objective of this study was to compare glucose metabolism and atrophy, in
the precuneus and cingulate cortex, in patients with Alzheimer’s disease (AD) and mild …

[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular
markers of hypoxia and angiogenesis | European Journal of Nuclear Medicine and Molecular …

Alzheimer's disease (AD), the most common age-related neurodegenerative disorder, is
characterized by the accumulation of β-amyloid peptide. In man, [18F]AV-45 with positron …

Recent reports have shown an increase in specific binding (in vitro) of [3H]PK 11195 to
peripheral-type benzodiazepine receptors in both experimental animals and humans, reflecting a …